Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where D. Kidron is active.

Publication


Featured researches published by D. Kidron.


Ultrasound in Obstetrics & Gynecology | 2016

Prediction of microcephaly at birth using three reference ranges for fetal head circumference: can we improve prenatal diagnosis?

Z. Leibovitz; E. Daniel‐Spiegel; G. Malinger; K.K. Haratz; M. Tamarkin; L. Gindes; L. Schreiber; Liat Ben-Sira; Dorit Lev; I. Shapiro; H. Bakry; B. Weizman; A. Zreik; S. Egenburg; A. Arad; Ronnie Tepper; D. Kidron; Tally Lerman-Sagie

To evaluate the prediction of microcephaly at birth (micB) using established and two new reference ranges for fetal head circumference (HC) and to assess whether integrating additional parameters can improve prediction.


Ultrasound in Obstetrics & Gynecology | 2015

Microcephaly at birth ‐ the accuracy of three references for fetal head circumference. How can we improve prediction?

Z. Leibovitz; E. Daniel‐Spiegel; G. Malinger; K.K. Haratz; M. Tamarkin; L. Gindes; Liat Ben-Sira; Dorit Lev; I. Shapiro; H. Bakry; B. Weizman; A. Zreik; S. Egenburg; A. Arad; Ronnie Tepper; D. Kidron; Tally Lerman-Sagie

To evaluate the prediction of microcephaly at birth (micB) using established and two new reference ranges for fetal head circumference (HC) and to assess whether integrating additional parameters can improve prediction.


International Journal of Gynecological Cancer | 2012

BRCA1 is expressed in uterine serous carcinoma (USC) and controls insulin-like growth factor I receptor (IGF-IR) gene expression in USC cell lines.

Keren Amichay; D. Kidron; Zohar Attias-Geva; Hagit Schayek; Rive Sarfstein; Ami Fishman; Haim Werner; Ilan Bruchim

Objective The insulin-like growth factor I receptor (IGF-IR) and BRCA1 affect cell growth and apoptosis. Little information is available about BRCA1 activity on the IGF signaling pathway. This study evaluated the effect of BRCA1 on IGF-IR expression. Methods BRCA1 and IGF-IR immunohistochemistry on archival tissues (35 uterine serous carcinomas [USCs] and 17 metastases) were performed. USPC1 and USPC2 cell lines were transiently cotransfected with an IGF-IR promoter construct driving a luciferase reporter gene and a BRCA1 expression plasmid. Endogenous IGF-IR levels were evaluated by Western immunoblotting. Results We found high BRCA1 and IGF-IR protein expression in primary and metastatic USC tumors. All samples were immunostained for BRCA1—71% strongly stained; and 33/35 (94%) were stained positive for IGF-IR—2 (6%) strongly stained. No difference in BRCA1 and IGF-IR staining intensity was noted between BRCA1/2 mutation carriers and noncarriers. Metastatic tumors stained more intensely for BRCA1 than did the primary tumor site (P = 0.041) and with borderline significance for IGF-IR (P = 0.069). BRCA1 and IGF-IR staining did not correlate to survival. BRCA1 expression led to 35% and 54% reduction in IGF-IR promoter activity in the USPC1 and USCP2 cell lines, respectively. Western immunoblotting showed a decline in phosphorylated IGF-IR and phosphorylated AKT in both transiently and stably transfected cells. Conclusions BRCA1 and IGF-IR are highly expressed in USC tumors. BRCA1 suppresses IGF-IR gene expression and activity. These findings suggest a possible biological link between the BRCA1 and the IGF-I signaling pathways in USC. The clinical implications of this association need to be explored.


Ultrasound in Obstetrics & Gynecology | 2016

Region‐specific reductions in brain apparent diffusion coefficient in cytomegalovirus‐infected fetuses

Gal Yaniv; Chen Hoffmann; Boaz Weisz; Shlomo Lipitz; E. Katorza; D. Kidron; Dafi Bergman; Anat Biegon

To evaluate the effects of cytomegalovirus (CMV) infection on apparent diffusion coefficient (ADC) values of the fetal brain in utero.


Ultrasound in Obstetrics & Gynecology | 2014

Region selective reductions in brain apparent diffusion coefficient in CMV-infected fetuses.

Gal Yaniv; Chen Hoffmann; Boaz Weisz; Shlomo Lipitz; E. Katorza; D. Kidron; Dafi Bergman; Anat Biegon

To evaluate the effects of cytomegalovirus (CMV) infection on apparent diffusion coefficient (ADC) values of the fetal brain in utero.


European Journal of Ophthalmology | 2015

Characterization of prostaglandin F2α receptors in human eyelids.

R. Nesher; Michael Mimouni; Halah Elnaddaf; Arie Y. Nemet; D. Kidron

Purpose Elongation, thickening, and crowding of eyelashes are commonly seen after topical use of prostaglandin analog eyedrops for glaucoma treatment. The purpose of this study was to demonstrate the presence and characterize the location of prostaglandin analog F2α receptors (PGF2α) in human hair follicles. Methods In this observational clinical laboratory study, excised eyelid specimens following eyelid surgery were studied. Resected portions of eyelids were submitted for histopathologic evaluation. For immunohistochemistry evaluation, a polyclonal antibody directed against PGF2α was purchased from Cayman Chemical. The staining procedure was carried out on an automatic stainer. Results Out of 26 patients recruited, final analysis was conducted on 17 eyes of 15 patients. There were 10 men and 5 women (mean age 77 ± 14 years). Staining was detected only in hair follicles in the anagen stage (37 slices). No variation in pattern, distribution, or intensity of immunostaining was noted among sections of different individuals. Only the bulb and stem of the hair follicle stained positive. In the bulb, the strongest staining occurred in the matricular cells and in the inner sheath layer. In the stem, the strongest staining occurred in the Huxley layer of the inner sheath. Conclusions This immunohistologic study found that PGF2α receptors were located predominantly in the inner root sheath of the bulb and stem of eyelashes and expressed only in eyelashes in the anagen phase.


Journal of Surgical Oncology | 2014

Evaluation of peritoneal CEA levels following colorectal cancer surgery

Liron Berkovich; Baruch Shpitz; Itzhak Greemland; Vladimir Kravtsov; D. Kidron; Moshe Mishaeli; Shmuel Avital

Peritoneal carcinoembryonic antigen (pCEA) levels in the early postoperative period following a curative resection of colorectal cancer (CRC) have not been previously studied.


Journal of Obstetrics and Gynaecology | 2017

The magnitude of elevated maternal serum human chorionic gonadotropin and pregnancy complications

Reuven Sharony; Oren Zipper; Keren Amichay; Amir Wiser; D. Kidron; Tal Biron-Shental; Ron Maymon

Abstract This study assessed the correlation between the magnitude of the elevation in maternal serum human chorionic gonadotropin (MShCG) levels and pregnancy complications. Among 80,716 screened pregnancies, 120 with moderately elevated MShCG (3.00–5.99 MoM) were compared to 84 with extremely elevated MShCG >6.00 MoM. A control series of 120 women with normal MShCG (<3.00 MoM) were matched. Rates of intrauterine growth restriction, preterm labour, antepartum foetal death (APFD), pre-eclampsia, and placental abruption were analysed. We found that the study group had more adverse outcomes than the control group (73/204 [36%] vs. 18/120 [15%]; p < .0001). The rate was higher in the extremely elevated group than in the moderately elevated group (43/84 [51%] vs. 30/120 [25%]; p < .0001). All 12 cases of APFD (14%) occurred among the extremely elevated series. In conclusion, adverse pregnancy outcomes are more common in women with extremely elevated MShCG. The patients should receive counselling regarding this trend and undergo close pregnancy monitoring. Impact statement • What is already known on this subject?In addition to its contribution to Down syndrome (DS) screening, maternal serum human chorionic gonadotropin (MShCG) levels are a marker for pregnancy complications such as intrauterine growth restriction (IUGR), preterm labour (PTL), antepartum fatal death (APFD), pre-eclampsia (PE), placental abruption (PA) and fetal malformations with or without chromosomal aberrations. • What the results of this study add? We found that in the presence of elevated MShCG levels, the incidence of IUGR and PTL increased. PE increased clinically, but statistical significance was seen only when MShCG was extremely elevated (≥ 6.00 MoM). APFD and PA were associated with very high MShCG levels only. • What the implications are of these findings for clinical practice and/or further research? Women with high MShCG levels should be counselled. In case of very high levels (≥ 6.00 MoM), the risk of APFD and PA should be discussed. The pregnancy should be monitored for IUGR, PTL and PE. In view of the limited number of enrolled patients with very high levels of MShCG, the experience of other institutions is needed to corroborate these findings.


Ultrasound in Obstetrics & Gynecology | 2016

Application of a novel prenatal vertical cranial biometric measurement can improve accuracy of microcephaly diagnosis in utero

Z. Leibovitz; C. Shiran; K.K. Haratz; M. Tamarkin; L. Gindes; L. Schreiber; G. Malinger; Liat Ben-Sira; Dorit Lev; I. Shapiro; H. Bakry; B. Weizman; A. Zreik; D. Kidron; S. Egenburg; A. Arad; Tally Lerman-Sagie

To construct a reference range for a new vertical measurement of the fetal head and to assess whether its combination with fetal head circumference (HC) can prevent the misdiagnosis of microcephaly in fetuses with an acrocephalic‐like head deformation.


Ultrasound in Obstetrics & Gynecology | 2016

Application of a novel prenatal nomogram for vertical cranial biometry can improve accuracy of microcephaly diagnosis in utero

Z. Leibovitz; C. Shiran; K.K. Haratz; M. Tamarkin; L. Gindes; L. Schreiber; G. Malinger; Liat Ben-Sira; Dorit Lev; I. Shapiro; H. Bakry; B. Weizman; A. Zreik; D. Kidron; S. Egenburg; A. Arad; Tally Lerman-Sagie

To construct a reference range for a new vertical measurement of the fetal head and to assess whether its combination with fetal head circumference (HC) can prevent the misdiagnosis of microcephaly in fetuses with an acrocephalic‐like head deformation.

Collaboration


Dive into the D. Kidron's collaboration.

Top Co-Authors

Avatar

Dorit Lev

Wolfson Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

I. Shapiro

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

K.K. Haratz

Wolfson Medical Center

View shared research outputs
Top Co-Authors

Avatar

L. Gindes

Wolfson Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Tamarkin

Wolfson Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge